Global Thrombectomy Devices Market Size study, by Product Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Other Product Types), Applications (Cardiovascular Thrombectomy, Neurovascular Thrombectomy,

Global Thrombectomy Devices Market Size study, by Product Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, Other Product Types), Applications (Cardiovascular Thrombectomy, Neurovascular Thrombectomy, Peripheral Vascular Thrombectomy), End-User (Hospitals/Clinics, Ambulatory Centers, Other End-Users), and Regional Forecasts 2022-2028

Global Thrombectomy Devices Market is valued at approximately USD 1.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2022-2028. Devices for thrombectomy are intended to prevent blood artery injury during surgery and limit blood loss. Acute myocardial infarction, peripheral artery disease, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis disorders are all treated with these devices. The market is driven by significant factors such as increased awareness regarding early diagnosis of diseases and technological advancements in medical devices used for capturing blood clots. For instance, in 2021, NeuroVasv announced the development of the ENVI-SR Mechanical Thrombectomy System (ENVI-SR), a stent-retriever for the removal of blood clots in patients with acute ischemic stroke caused by major artery obstruction. Meanwhile, more innovative devices becoming approved fuels market expansion. For instance, the AlphaVac mechanical thrombectomy system, an off-circuit, multi-purpose mechanical aspiration thrombectomy device, was approved by the U.S. Food and Drug Administration (FDA) in January 2021. It is used to remove thrombi or emboli from the vascular non-surgically. Moreover, increasing Number of research activities in the field of thrombectomy and expanding application of ultrasound in vascular treatment creates lucrative opportunities in the upcoming years. However, High Cost and difficultly use of devices for complex morphologies impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Thrombectomy Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share revenue owing to increasing burden of cardiac patients, technological advancements in the devices. However, Asia Pacific expected to be the fastest growing region due to increase in government insurance coverage in developing countries, rise in approval of new innovative embolization.

Major market players included in this report are:
Koninklijke Philips NV (Spectranetics)
Argon Medical Devices Inc.
Terumo Corporation
Boston Scientific Corporation
Edwards Lifesciences Corporation
Stryker Corporation
Straub Medical AG
Johnson & Johnson
Medtronic PLC
Penumbra Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Aspiration Thrombectomy Devices
Mechanical Thrombectomy Devices
Ultrasonic Thrombectomy Devices
Other Product Types
By Application:
Cardiovascular Thrombectomy
Neurovascular Thrombectomy
Peripheral Vascular Thrombectomy
By End User:
Hospitals/Clinics
Ambulatory Centers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Thrombectomy Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Koninklijke Philips NV (Spectranetics)
Argon Medical Devices Inc.
Terumo Corporation
Boston Scientific Corporation
Edwards Lifesciences Corporation
Stryker Corporation
Straub Medical AG
Johnson & Johnson
Medtronic PLC
Penumbra Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.